Rsid |
Chr |
Position |
P value |
Ref |
Alt |
Gwas trait |
Gene symbol |
Variant type |
PMID |
rs6876835 |
chr5 |
6599222 |
0.000003 |
A |
G |
Visceral fat |
NSUN2 |
nearGene-3 |
22589738
|
rs6876835 |
chr5 |
6599222 |
0.0000451 |
A |
G |
Body Fat Distribution |
NSUN2 |
nearGene-3 |
pha003016
|
rs6555404 |
chr5 |
6606445 |
0.00000998 |
G |
A |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs6884320 |
chr5 |
6612027 |
0.00000452 |
T |
C |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs4701742 |
chr5 |
6613827 |
0.000604 |
T |
C |
Insulin resistance |
NSUN2 |
intron |
21901158
|
rs3776431 |
chr5 |
6618756 |
0.00000352 |
T |
C |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs2288445 |
chr5 |
6620092 |
0.0000011 |
C |
T |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs2303705 |
chr5 |
6622017 |
0.0000028 |
T |
G |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs11744948 |
chr5 |
6622790 |
0.0000027 |
G |
A |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs12691276 |
chr5 |
6623085 |
0.0000007 |
T |
C |
Urinary metabolites |
NSUN2 |
intron |
21572414
|
rs10037161 |
chr5 |
6624294 |
0.00000256 |
C |
A |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs6874005 |
chr5 |
6624371 |
0.00000284 |
C |
T |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs2288447 |
chr5 |
6626091 |
0.00000903 |
G |
A |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs10076470 |
chr5 |
6632875 |
0.00000114 |
G |
A |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs571550 |
chr5 |
6632909 |
0.00000726 |
G |
A |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs193743 |
chr5 |
6632942 |
0.00000753 |
G |
T |
Response to amphetamines |
NSUN2 |
intron |
22952603
|
rs4702373 |
chr5 |
6633222 |
0.00000132 |
C |
T |
Response to amphetamines |
NSUN2 |
UTR-5 |
22952603
|